Mark R. Kelley

16.1k citations
223 papers · 13.7k · 1 hit paper · h-index 66

Impact in

    • DNA Repair Mechanisms
    • Epigenetics and DNA Methylation
    • Advanced biosensing and bioanalysis techniques
    • DNA and Nucleic Acid Chemistry
    • RNA modifications and cancer
    • CRISPR and Genetic Engineering
    • Cancer therapeutics and mechanisms
  • Oncology top 1%
    • PARP inhibition in cancer therapy

Papers in

    • DNA Repair Mechanisms 102
    • RNA modifications and cancer 19
    • Epigenetics and DNA Methylation 18
    • CRISPR and Genetic Engineering 17
    • Cancer therapeutics and mechanisms 16
    • DNA and Nucleic Acid Chemistry 13
    • PARP inhibition in cancer therapy 15

Mark R. Kelley

220 papers receiving 13.4k citations

Mark R. Kelley's Hit Papers

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update 2020 · 748 citations
7480+2+4Years since publication200400600

Peers

Mark R. Kelley
Comparison fields: 5 of 140
  • Molecular Biology 9.1k
  • Oncology 3.0k
  • Cancer Research 1.3k
  • Aging 129
  • Physiology 329
Replace Michael J. Weber with:
Michael J. Weber United States
Masafumi Tsujimoto Japan
John M. Kyriakis United States
Quentin Liu China
Steven Pelech Canada
Lester F. Lau United States
Richard A. Roth United States
Sheng‐Cai Lin China
Tullio Florio Italy
Ángel R. Nebreda Spain
Mark R. Kelley relative to Michael J. Weber United States Michael J. Weber's profile →
Citations per field
00.5×2×3×4.1×
Michael J. Weber · 1×
Citations per year

Countries citing papers authored by Mark R. Kelley

Since Specialization
Citations

This map shows the geographic impact of Mark R. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Kelley more than expected).

Fields of papers citing papers by Mark R. Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Kelley. The network helps show where Mark R. Kelley may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark R. Kelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark R. Kelley Line = papers co-authored together Mark R. Kelley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Hit paper breakdown →
2020748
2 2000488
3 2008435
4 1986363
5 2005337
6 1986319
7 2018305
8 2007250
9 2002249
10 2006225
11 2004214
12 2009212
13 1987199
14
Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
2001178
15
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
2001175
16 2014164
17 2008152
18 2011145
19 1987133
20 1992132

About Mark R. Kelley

Mark R. Kelley is a scholar working on Molecular Biology, Oncology, Cancer Research, Reproductive Medicine and Endocrinology, Diabetes and Metabolism, having authored 223 papers that have together received 13.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (102 papers), RNA modifications and cancer (19 papers), Epigenetics and DNA Methylation (18 papers), CRISPR and Genetic Engineering (17 papers), Cancer therapeutics and mechanisms (16 papers), PARP inhibition in cancer therapy (15 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and DNA and Nucleic Acid Chemistry (13 papers). The work is most often cited by research in Molecular Biology (9.1k citations), Oncology (3.0k citations), Cancer Research (1.3k citations), Aging (129 citations) and Physiology (329 citations). Mark R. Kelley has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Melissa L. Fishel, Simon Kidd, Gianluca Tell, Walter A. Deutsch, Meihua Luo, Michael R. Vasko, Millie M. Georgiadis, Angela R. Evans, Martin Lloyd Smith and Franco Quadrifoglio. Their work appears in journals such as Journal of Biological Chemistry, DNA repair, Molecular and Cellular Biology, Antioxidants and Redox Signaling and Mutation Research/DNA Repair.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact